Analytical Data
-
基因名
OPI
- Application
-
别名
OPI；OPRK；Kappa-type opioid receptor
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P41145
-
表达区间
1-380aa
-
氨基酸序列
MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV
-
分子量
42.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OPI (Oligomeric Protein Inhibitor) recombinant proteins have garnered significant attention in the field of molecular biology and therapeutic development due to their potential applications in various biomedical areas. The research surrounding OPI proteins focuses on their role as powerful inhibitors that can modulate protein interactions and cellular functions. These recombinant proteins are engineered to mimic natural inhibitors, providing a promising approach for therapeutic interventions in diseases characterized by abnormal protein interactions, such as cancer, neurodegenerative disorders, and infectious diseases. Advances in recombinant DNA technology have allowed for the high-yield production of these proteins, facilitating detailed studies into their structure-function relationships and mechanisms of action. Ongoing research aims to enhance the specificity and efficacy of OPI proteins, exploring their use in drug design, targeted therapies, and as diagnostic tools. Additionally, the interdisciplinary nature of this research brings together biochemistry, structural biology, and pharmacology, highlighting the importance of OPI proteins in developing innovative solutions for complex health challenges.
